Investor relations
Carasent offers mission-critial solutions like Electronic Health Records (EHR), Medical Clinic Management Software, patient engagement solutions, and business intelligence tools across various health and care sectors. In a world where efficiency and sustainability are paramount, Carasent ASA is at the forefront of providing solutions that alleviate the burden on the health and care systems.
Key figures in 2023
NOK in revenue 2023
0
M
NOK ARR DEC 2023
0
M
adj. EBITDA MARGIN 2023
0
%
YoY Revenue growth 2023
0
%
Interim report Q2, 2024
Stockholm Relisting Process
Merger plan and related documentation:
01 Merger Plan Carasent ASA and Carasent AB (publ)
Appendix 1 – AoA Carasent ASA
Appendix 2 – Current AoA
Appendix 3 – Adapted AoA
Appendix 4 – Annual Report 2021
Appendix 5 – Annual Report 2022
Appendix 6 – Annual Report 2023
Appendix 7 – Interim Report H1 2024
Appendix 8 – KPMG AB Statement
Appendix 9 – KPMG AS Statement
Appendix 10 – Joint Statement by the Board of Directors
Appendix 11 – Message to Shareholders, Creditors and Employees
Capital Markets Day 2023
On November 7th 2023, Carasent hosted a Capital Markets Day at Carnegie head office in Stockholm. If you missed the event, you can view the recorded webcast and the presentation here:
Stock exchange releases
Subscribe to our pressreleases
Are you curious to hear more?
2024 Carasent. All rights reserved by Carasent ASA.
